Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 3901–3950 of 33040
each of Milton Brown, Bette Jacobs, Chris Senanayake and Joshua Shafer resigned as directors of the Company
each of Milton Brown, Bette Jacobs, Chris Senanayake and Joshua Shafer resigned as directors of the Company
each of Milton Brown, Bette Jacobs, Chris Senanayake and Joshua Shafer resigned as directors of the Company
On February 26, 2025, Lim P. Nguonly, a director of John Marshall Bancorp, Inc. (the “Company”) and John Marshall Bank (the “Bank”), a wholly-owned subsidiary of the Company, notified the Company and the Bank that he will not stand for re-election to the Board of Directors of the Company at its 2025 annual meeting of shareholders and will retire from the Boards of Directors of the Company and the Bank effective at the conclusion of the next Board of Directors meeting to be held on March 18, 2025.
On February 24, 2025, Rory Riggs resigned as the Chief Executive Officer of Cibus, Inc.
On February 27, 2025, Dawn Smajstrla ceased to serve as Chief Accounting Officer of Sitio Royalties Corp.
As previously reported, on February 17, 2025, Anthony Querciagrossa informed the Board of Directors (the “Board”) of Pinstripes Holdings, Inc. (the “Company”) of his resignation as Chief Financial Officer of the Company, effective February 28, 2025.
who on February 24, 2025 informed the Company that he will retire as Executive Vice President and Chief Financial Officer of the Company, effective April 1, 2025.
On February 26, 2025, Ziv Shoshani resigned from the Board of Directors of Vishay Intertechnology, Inc. ("the Company"), effective immediately before the election of directors at the Company’s annual meeting of stockholders on May 20, 2025, in order to devote his full business time and attention to Vishay Precision Group, Inc., which he serves as President and Chief Executive Officer and as a member of the board.
On February 26, 2025, Mary T. McDowell informed the Board of her intention not to stand for re-election at Autodesk's 2025 Annual Meeting of Stockholders.
On February 27, 2025, Cisco and Gary Steele, President, Go-to-Market of Cisco, agreed to change the effective date of his previously announced resignation from Cisco to May 12, 2025.
the Company is reporting that Doug Miller, the Company’s President and Chief Commercial Officer is departing from the Company to pursue other opportunities.
On February 24, 2025, Ms. Sherry Aulin notified the Company of her decision to resign as Chief Financial Officer, effective June 30, 2025, for personal reasons.
The Company previously announced that Richard Booth, the Company’s current CFO, would be departing the Company effective June 1, 2025.
On February 24, 2025, Bill Wagner, a member of the Board of Directors (the “Board”) of Akamai Technologies, Inc. (the “Company”), notified the Company of his intent to resign from the Board, effective immediately, due to his acceptance of a new role as Chief Executive Officer of Semrush Holdings, Inc.
On February 24, 2025, Jon Kaplan voluntarily resigned from his position as a member of the Board.
On February 24, Leigh Morgan, a member of the Board of Directors (the “Board”) of the Company, the Compensation and Talent Committee of the Board, and a member and chair of the Nominating and Corporate Governance Committee of the Board, informed the Company that she does not intend to stand for reelection at the Company’s 2025 annual meeting of shareholders.
Mr. Simon provided notice of his resignation on February 25, 2025 and will be leaving the Company at the end of May.
On February 25, 2025, Ignacio Alvarez announced his retirement as Chief Executive Officer (“CEO”) of Popular, Inc. (“Popular” or the “Corporation”), effective June 30, 2025 (the “Retirement Date”).
David McJannet, Armon Memaran-Dadgar, Glenn Solomon, Susan St. Ledger, Todd Ford, Sigal Zarmi and David Henshall, each of whom was a director of HashiCorp as of immediately prior to the Effective Time, ceased to be a director of HashiCorp
David McJannet, Paul Warenski and Werner Schwok, each of whom was an officer of HashiCorp as of immediately prior to the Effective Time, ceased to be an officer of HashiCorp
David McJannet, Armon Memaran-Dadgar, Glenn Solomon, Susan St. Ledger, Todd Ford, Sigal Zarmi and David Henshall, each of whom was a director of HashiCorp as of immediately prior to the Effective Time, ceased to be a director of HashiCorp
David McJannet, Paul Warenski and Werner Schwok, each of whom was an officer of HashiCorp as of immediately prior to the Effective Time, ceased to be an officer of HashiCorp
David McJannet, Armon Memaran-Dadgar, Glenn Solomon, Susan St. Ledger, Todd Ford, Sigal Zarmi and David Henshall, each of whom was a director of HashiCorp as of immediately prior to the Effective Time, ceased to be a director of HashiCorp
David McJannet, Armon Memaran-Dadgar, Glenn Solomon, Susan St. Ledger, Todd Ford, Sigal Zarmi and David Henshall, each of whom was a director of HashiCorp as of immediately prior to the Effective Time, ceased to be a director of HashiCorp
David McJannet, Armon Memaran-Dadgar, Glenn Solomon, Susan St. Ledger, Todd Ford, Sigal Zarmi and David Henshall, each of whom was a director of HashiCorp as of immediately prior to the Effective Time, ceased to be a director of HashiCorp
David McJannet, Armon Memaran-Dadgar, Glenn Solomon, Susan St. Ledger, Todd Ford, Sigal Zarmi and David Henshall, each of whom was a director of HashiCorp as of immediately prior to the Effective Time, ceased to be a director of HashiCorp
David McJannet, Paul Warenski and Werner Schwok, each of whom was an officer of HashiCorp as of immediately prior to the Effective Time, ceased to be an officer of HashiCorp
David McJannet, Armon Memaran-Dadgar, Glenn Solomon, Susan St. Ledger, Todd Ford, Sigal Zarmi and David Henshall, each of whom was a director of HashiCorp as of immediately prior to the Effective Time, ceased to be a director of HashiCorp
Each of Andrew Spaventa, the Company’s Chief Executive Officer and Chair of the Company’s Board, Eli Glezer, Ph.D., the Company’s Chief Scientific Officer and Dalen Meeter, the Company’s Chief Financial Officer resigned from the Company, effective as of immediately prior to the Effective Time.
Each of Andrew Spaventa, the Company’s Chief Executive Officer and Chair of the Company’s Board, Eli Glezer, Ph.D., the Company’s Chief Scientific Officer and Dalen Meeter, the Company’s Chief Financial Officer resigned from the Company, effective as of immediately prior to the Effective Time.
Each of Andrew Spaventa, the Company’s Chief Executive Officer and Chair of the Company’s Board, Eli Glezer, Ph.D., the Company’s Chief Scientific Officer and Dalen Meeter, the Company’s Chief Financial Officer resigned from the Company, effective as of immediately prior to the Effective Time.
Each of Andrew Spaventa, the Company’s Chief Executive Officer and Chair of the Company’s Board, Eli Glezer, Ph.D., the Company’s Chief Scientific Officer and Dalen Meeter, the Company’s Chief Financial Officer resigned from the Company, effective as of immediately prior to the Effective Time.
On February 22, 2025, Lisa von Moltke, M.D. notified Seres Therapeutics, Inc. (the “Company”) of her intention to resign as the Executive Vice President and Chief Medical Officer of the Company, effective as of March 14, 2025.
Tamara L. Schock, notified the Company of her intent to resign as Executive Vice President and Chief Accounting Officer of the Company.
Ms. Spofford has agreed to extend her retirement date to April 30, 2025
On February 13, 2025, Liu Yu resigned from his position as Chief Operating Officer, Chief Scientific Officer and Head of Research of Graphjet Technology (the “Company”), effective immediately.
On February 27, 2025, the Company terminated the employment of Jorge Aldecoa as the Company’s Chief Product Officer, effective immediately.
On February 21, 2025, Tao Han notified Maison Solutions Inc. (the “Company”) of his resignation as Chief Operating Officer of the Company, effective immediately.
On February 24, 2025, the Company’s Chief Medical Officer, Dr. Scott Harris, provided the Company advance notice of his intention to retire from Altimmune as of February 28, 2026.
On February 23, 2025, Garth Graham resigned from the Board of Directors (the “ Board ”) of ModivCare Inc. (the “ Company ”), effective as of February 28, 2025.
On February 26, 2025, John A. Forbes resigned as a member of our Board of Directors.
On February 24, 2025, Marc Zandman resigned from the board of directors of Vishay Precision Group, Inc., a Delaware corporation (the “Company”), effective immediately before the election of directors at the Company’s annual meeting of stockholders, which is expected to be held on May 21, 2025
Christa Mitchell, Chief Strategy Officer of Pineapple Financial Inc. (the “Company”), notified the Company that she would resign as Chief Strategy Officer, effective March 7, 2025.
accepted the resignation of Thomas Hess as Chief Financial Officer of the Company, effective as of March 26, 2025.
On February 24, 2025, Deborah Macdonald notified Kinder Morgan, Inc. (“KMI”) that she will retire from KMI’s Board of Directors (the “Board”) at the end of her current term and consequently will not stand for re-election to the Board at KMI’s 2025 annual meeting of stockholders in May (the “2025 Annual Meeting”).
Effective February 26, 2025, Adrian I. Peace will no longer serve in the role of President, Performance Technologies for Modine Manufacturing Company (the "Company") and will terminate employment with the Company on September 30, 2025.
On February 24, 2025, Michael D. Cahill, VWF Bancorp Inc.'s (the "Company") President and Chief Executive Officer, a member of the Board of Directors of the Company, the Company's subsidiary GreenWay Bank's (the "Bank") President and Chief Executive Officer, and a member of the Board of Directors of the Bank, notified the Company and the Bank that he will retire from the Company and the Bank, at the end of the current term of his employment agreement, effective December 31, 2025.
On February 27, 2025, the Company announced that Shirley Kuhlmann, Executive Vice President, Chief Administrative Officer, General Counsel & Secretary of the Company will step down from her positions at the Company effective March 7, 2025.
On February 24, 2025, Steven Tuch, Executive Vice President and Chief Financial Officer of vTv Therapeutics Inc. (the "Company"), informed the Company of his intention to resign from his position effective March 21, 2025.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.